# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Mitochondrial disorders

Mitochondrial genetic disordersMitochondrial diseases
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 41-50 of 60 results.
New Non-invasive Modalities for Assessing Retinal Structure and Function
Status: Recruiting
Last Changed: May 09, 2019
First Received: Mar 23, 2018
Disease(s): Ischemic Optic Neuropathy, Branch Retinal Artery Occlusion, Hemianopia, Leber Hereditary Optic Neuropathy, Acute Zonal Occult Outer Retinopathy
Intervention(s): LSFG-NAVI
Locations: University of Iowa Department of Ophthalmology, Iowa City, Iowa, United States
Neurology Measures in FA Children
Status: Recruiting
Last Changed: Apr 29, 2020
First Received: Feb 01, 2018
Disease(s): Friedreich Ataxia
Locations: University of California, Los Angeles, Los Angeles, California, United States
University of Florida, Gainesville, Florida, United States
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Expanded Access Program for Idebenone in Patients With Leber's Hereditary Optic Neuropathy Who Completed the LEROS Study
Status: Available
Last Changed: May 08, 2020
First Received: May 08, 2020
Disease(s): Leber's Hereditary Optic Neuropathy
Intervention(s): Idebenone 150 MG Oral Tablet
Instrumented Data Exchange for Ataxia Study
Status: Recruiting
Last Changed: Feb 13, 2020
First Received: Feb 13, 2020
Disease(s): Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2, Spinocerebellar Ataxia Type 3, Spinocerebellar Ataxia Type 6, Friedreich Ataxia
Locations: University of California-Los Angeles, Los Angeles, California, United States
The University of Chicago, Chicago, Illinois, United States
Johns Hopkins Medicine, Baltimore, Maryland, United States
Mass General Hospital, Boston, Massachusetts, United States
A Natural History Study to TRACK Brain and Spinal Cord Changes in Individuals With Friedreich Ataxia (TRACK-FA)
Status: Not yet recruiting
Last Changed: Jul 20, 2020
First Received: Apr 16, 2020
Disease(s): Friedreich Ataxia
Intervention(s): Natural history
Locations: University of Florida, Gainesville, Florida, United States
Center for Magnetic Resonance Research, University of Minnesota, Minneapolis, Minnesota, United States
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Monash Biomedical Imaging, Monash University, Clayton, Victoria, Australia
Lab of Neuroimaging and Dept of Neurology, University of Campinas (UNICAMP), São Paulo, Brazil
... and 2 other locations.
Micronised Resveratrol as a Treatment for Friedreich Ataxia
Status: Recruiting
Last Changed: Aug 14, 2019
First Received: May 01, 2019
Disease(s): Friedreich Ataxia
Intervention(s): Resveratrol
Locations: University of Queensland Centre for Clinical Research, Herston, Queensland, Australia
Murdoch Children's Research Institute, Parkville, Victoria, Australia
Royal Perth Hospital, Perth, Western Australia, Australia
Biomarkers in Friedreich's Ataxia
Status: Recruiting
Last Changed: Jun 11, 2020
First Received: Jul 14, 2015
Disease(s): Friedreich's Ataxia
Locations: University of Florida, Gainesville, Florida, United States
Patient Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS)
Status: Recruiting
Last Changed: Mar 02, 2020
First Received: Feb 24, 2014
Disease(s): Friedreich's Ataxia
Locations: Medical University Innsbruck, Department of Neurology, Innsbruck, Austria
Université Libre de Bruxelles, Bruxelles, Belgium
Hôpital Pitié Salpêtrière, Paris, France
Hôptal de Hautepierre, Department of Neurology, Strasbourg, France
University Hospital Aachen, Dept. of Neurology, Aachen, Germany
... and 8 other locations.
ABI-009 (Nab-sirolimus) in Patients With Genetically-confirmed Leigh or Leigh-like Syndrome
Status: Not yet recruiting
Last Changed: Jul 16, 2020
First Received: Nov 20, 2018
Disease(s): Leigh Syndrome
Intervention(s): ABI-009
Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency:
Status: Recruiting
Last Changed: Jul 17, 2020
First Received: Nov 30, 2015
Disease(s): Pyruvate Dehydrogenase Complex Deficiency
Intervention(s): Dichloroacetate (DCA), Placebo, Genotype
Locations: Children's Hospital of Orange County, Orange, California, United States
Stanford University, Stanford, California, United States
Children's National Medical Center, Washington, District of Columbia, United States
University of Florida, Gainesville, Florida, United States
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
... and 5 other locations.